Skip to content

Application value of 3D printing heart model assisted ventricular septal resection in patients with hypertrophic obstructive cardiomyopathy: a prospective randomized controlled trial

Application value of 3D printing heart model assisted ventricular septal resection in patients with hypertrophic obstructive cardiomyopathy: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113426
Enrollment
Unknown
Registered
2025-11-28
Start date
2025-11-28
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Obstructive Cardiomyopathy

Interventions

Experimental Group:3D-Printed Cardiac Model-Assisted Septal Myectomy Pre-operative Planning: An individualized cardiac model (typically made of flexible photopolymer resin) will be 3D-printed at a 1:1
Control group:Conventional Septal Myectomy Pre-operative Planning: The surgical team will rely solely on conventional two-dimensional echocardiography, cardiac CT, or MRI images for pre-operative anal

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Diagnosed with drug-refractory hypertrophic obstructive cardiomyopathy. 2)Scheduled to undergo the modified Morrow procedure. 3)Availability of pre-operative cardiac ultrasound (echocardiography) images. 4)Age >= 14 and <= 80 years.

Exclusion criteria

Exclusion criteria: 1)Presence of any surgical contraindications (e.g., uncontrolled infection, irreversible severe pulmonary hypertension, etc.). 2)Pre-operative left ventricular ejection fraction (LVEF) < 0.3. 3)Previous history of Morrow procedure. 4)Poor-quality pre-operative echocardiographic images that preclude accurate assessment of the left ventricular outflow tract pressure gradient. 5)Concurrent acute myocardial infarction with onset within less than 7 days. 6)Comorbid with severe hepatic, renal, or pulmonary failure, or any other disease with a life expectancy of < 1 year. 7)Requirement for concomitant other complex cardiac surgical procedures.

Design outcomes

Primary

MeasureTime frame
Rate of achieving postoperative LVOT gradient = 10 mmHg;

Countries

China

Contacts

Public ContactYin Zongtao

General Hospital of Northern Theater Command

yzt711210@sina.com+86 133 0988 1423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026